Street Calls of the Week
Copart NASDAQ:CPRT Chief Executive Officer Jeffrey Liaw sold 24,283 shares of common stock on October 15, 2025, for approximately $1.08 million. The sales occurred in a price range of $44.7902 to $44.8028. The transaction comes as Copart’s stock trades near its 52-week low of $43.32, having declined about 26% over the past six months. InvestingPro analysis shows the company maintains strong financial health with a GREAT overall score.
According to a Form 4 filing with the Securities and Exchange Commission, the transactions were executed automatically pursuant to a Rule 10b5-1 trading plan adopted by Liaw on April 15, 2025.
On the same day, Liaw also exercised options to acquire 49,766 shares of Copart common stock at exercise prices of $6.78 and $8.70, for a total value of $422805. These options were related to employee stock option plans. The options with an exercise price of $6.78, became exercisable beginning October 10, 2018, and the options with an exercise price of $8.70, became exercisable beginning October 4, 2019.
Following these transactions, Liaw directly owns 31,332 shares of Copart NASDAQ:CPRT.
In other recent news, Copart Inc . reported its fourth-quarter earnings for fiscal year 2025, surpassing analysts’ expectations with an earnings per share (EPS) of $0.41, compared to the forecasted $0.36. However, the company’s revenue slightly missed expectations, coming in at $1.13 billion against the anticipated $1.14 billion. CFRA lowered its price target on Copart to $65 from $70, maintaining a Strong Buy rating, citing a slight valuation discount compared to historical averages. Similarly, Stephens reduced its price target to $46 from $50, maintaining an Equal Weight rating due to competitive concerns. Despite these adjustments, Copart’s recent earnings performance was positively received, with the market reacting favorably to its strategic focus on technology and auction liquidity. The company’s stock saw a positive reaction, although the price movement is not discussed here. These developments reflect ongoing analyst evaluations and market responses to Copart’s financial health and strategic initiatives.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.